Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Alterity Therapeutics Ltd ADR (NQ: ATHE ) 1.300 -0.020 (-1.52%) Streaming Delayed Price Updated: 3:13 PM EDT, Aug 23, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,966 Open 1.331 Bid (Size) 1.290 (9) Ask (Size) 1.360 (3) Prev. Close 1.320 Today's Range 1.294 - 1.340 52wk Range 1.010 - 5.410 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Appendix 4C – Q4 FY24 Quarterly Cash Flow Report July 31, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics to Present at MST Financial Webinar July 24, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Performance YTD -47.58% -47.58% 1 Month -18.75% -18.75% 3 Month -33.33% -33.33% 6 Month -29.35% -29.35% 1 Year -51.31% -51.31% More News Read More Alterity Therapeutics Reports Positive Interim Data from ATH434-202 Phase 2 Clinical Trial in Multiple System Atrophy July 17, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics to Present at the MST Access ‘Hidden Gems in Life Sciences’ Webinar June 12, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics to Host Webcast Today on New Data from the bioMUSE Natural History Study May 29, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session May 27, 2024 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session May 10, 2024 Via Benzinga Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review May 08, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Friday's Pre-Market Session May 03, 2024 Via Benzinga Appendix 4C – Q3 FY24 Quarterly Cash Flow Report April 30, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics Presents New Data Demonstrating Potential of ATH434 to Treat Rare Neurodegenerative Disease Friedreich’s Ataxia April 29, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Wednesday's Intraday Session April 24, 2024 Via Benzinga 12 Health Care Stocks Moving In Tuesday's After-Market Session April 23, 2024 Via Benzinga Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting April 17, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Monday's After-Market Session April 15, 2024 Via Benzinga Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Intraday Session April 15, 2024 Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session April 15, 2024 Via Benzinga Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024 April 10, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund March 26, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting February 20, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire 12 Health Care Stocks Moving In Tuesday's Pre-Market Session February 06, 2024 Via Benzinga Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review February 06, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week January 29, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones January 22, 2024 From ALTERITY THERAPEUTICS LIMITED Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
